Status:
COMPLETED
Self Abrading Rapidly Applied Electrode Validation
Lead Sponsor:
Cleveland Medical Devices Inc
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
ELECTROENCEPHALOGRAPHIC VARIANT PATTERN 1 (Disorder)
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
The SARA (Self Abrading Rapidly Applied) electrode will speed EEG patient hookup by combining multiple steps that burden conventional EEG procedures into one. The investigators believe that the propos...
Detailed Description
The SARA (Self Abrading Rapidly Applied) electrode will speed EEG patient hookup by combining multiple steps that burden conventional EEG procedures into one. This proposed single-use electrode will c...
Eligibility Criteria
Inclusion
- adult and teenage
Exclusion
- young children
- damaged scalp skin
- sensitive or allergic to electrode paste
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02200523
Start Date
June 1 2014
End Date
December 1 2015
Last Update
August 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MetroHealth Research Institute
Cleveland, Ohio, United States, 44109